CPPIB Invests in Sigilon Therapeutics
Posted on 03/18/2020
On March 17, 2020, Cambridge, Massachusetts-based Sigilon Therapeutics, Inc. raised US$ 80.3 million in a Series B financing round. Sigilon Therapeutics is a biotechnology company developing functional cures for patients with chronic diseases. Investors in the found include Canada Pension Plan Investment Board (CPPIB), Longevity Vision Fund, and funds managed by BlackRock. Other investors in […]
